| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 17/02/2022 | 19:26 | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | USOTC:AGGX | AngioGenex Inc (CE) |
| 17/12/2021 | 21:41 | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without Registration (d) | USOTC:AGGX | AngioGenex Inc (CE) |
| 16/12/2021 | 12:02 | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:AGGX | AngioGenex Inc (CE) |
| 13/07/2020 | 21:06 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | USOTC:AGGX | AngioGenex Inc (CE) |
| 14/08/2019 | 23:11 | Edgar (US Regulatory) | Quarterly Report (10-q) | USOTC:AGGX | AngioGenex Inc (CE) |
| 15/05/2019 | 23:01 | Edgar (US Regulatory) | Notification That Quarterly Report Will Be Submitted Late (nt 10-q) | USOTC:AGGX | AngioGenex Inc (CE) |
| 01/04/2019 | 18:59 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | USOTC:AGGX | AngioGenex Inc (CE) |
| 28/03/2019 | 21:50 | Edgar (US Regulatory) | Annual Report (10-k) | USOTC:AGGX | AngioGenex Inc (CE) |
| 04/02/2019 | 23:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | USOTC:AGGX | AngioGenex Inc (CE) |
| 29/09/2017 | 23:33 | Edgar (US Regulatory) | Amended Securities Registration (section 12(g)) (10-12g/a) | USOTC:AGGX | AngioGenex Inc (CE) |
| 22/08/2017 | 23:00 | Edgar (US Regulatory) | Securities Registration (section 12(g)) (10-12g) | USOTC:AGGX | AngioGenex Inc (CE) |
| 22/08/2017 | 22:12 | Edgar (US Regulatory) | Withdrawal of Registration Statement (rw) | USOTC:AGGX | AngioGenex Inc (CE) |
| 31/03/2010 | 21:45 | Edgar (US Regulatory) | Notification that Annual Report will be submitted late (NT 10-K) | USOTC:AGGX | AngioGenex Inc (CE) |
| 09/01/2010 | 02:24 | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | USOTC:AGGX | AngioGenex Inc (CE) |
| 04/12/2009 | 22:38 | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | USOTC:AGGX | AngioGenex Inc (CE) |
| 03/12/2009 | 12:02 | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without Registration (D) | USOTC:AGGX | AngioGenex Inc (CE) |
| 23/11/2009 | 23:21 | Edgar (US Regulatory) | Quarterly Report (10-Q) | USOTC:AGGX | AngioGenex Inc (CE) |
| 16/11/2009 | 19:22 | Edgar (US Regulatory) | Notification that Quarterly Report will be submitted late (NT 10-Q) | USOTC:AGGX | AngioGenex Inc (CE) |
| 12/05/2009 | 22:16 | Edgar (US Regulatory) | Current report filing (8-K) | USOTC:AGGX | AngioGenex Inc (CE) |
| 14/04/2009 | 21:35 | Edgar (US Regulatory) | Annual Report (10-K) | USOTC:AGGX | AngioGenex Inc (CE) |
| 18/09/2008 | 21:01 | Edgar (US Regulatory) | Angiogenex, Inc. - Initial Statement of Beneficial Ownership (3) | USOTC:AGGX | AngioGenex Inc (CE) |
| 16/09/2008 | 18:52 | Edgar (US Regulatory) | Angiogenex, Inc. - Statement of Changes in Beneficial Ownership (4) | USOTC:AGGX | AngioGenex Inc (CE) |
| 14/08/2008 | 16:37 | Edgar (US Regulatory) | Angiogenex, Inc. - Quarterly Report (10-Q) | USOTC:AGGX | AngioGenex Inc (CE) |
| 25/07/2008 | 18:05 | Edgar (US Regulatory) | Angiogenex, Inc. - Current report filing (8-K) | USOTC:AGGX | AngioGenex Inc (CE) |
| 14/05/2008 | 19:31 | Edgar (US Regulatory) | Angiogenex, Inc. - Quarterly Report of Financial Condition (10QSB) | USOTC:AGGX | AngioGenex Inc (CE) |
| 02/04/2008 | 22:54 | Edgar (US Regulatory) | Angiogenex, Inc. - Annual Report (Small Business Issuers) (10KSB) | USOTC:AGGX | AngioGenex Inc (CE) |
| 31/03/2008 | 21:30 | Edgar (US Regulatory) | Angiogenex, Inc. - Notification that Annual Report will be submitted late (NT 10-K) | USOTC:AGGX | AngioGenex Inc (CE) |
| 14/02/2008 | 20:50 | Edgar (US Regulatory) | Angiogenex, Inc. - Annual Statement of Changes in Beneficial Ownership (5) | USOTC:AGGX | AngioGenex Inc (CE) |
| 14/02/2008 | 20:46 | Edgar (US Regulatory) | Angiogenex, Inc. - Amended Statement of Beneficial Ownership (3/A) | USOTC:AGGX | AngioGenex Inc (CE) |
| 19/11/2007 | 19:22 | Edgar (US Regulatory) | Angiogenex, Inc. - Proxy Statement (definitive) (DEF 14A) | USOTC:AGGX | AngioGenex Inc (CE) |